Logo image of CHRW

C.H. ROBINSON WORLDWIDE INC (CHRW) Stock Fundamental Analysis

NASDAQ:CHRW - Nasdaq - US12541W2098 - Common Stock - Currency: USD

100.88  +0.46 (+0.46%)

After market: 100.88 0 (0%)

Fundamental Rating

5

Overall CHRW gets a fundamental rating of 5 out of 10. We evaluated CHRW against 23 industry peers in the Air Freight & Logistics industry. CHRW scores excellent on profitability, but there are some minor concerns on its financial health. CHRW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CHRW had positive earnings in the past year.
In the past year CHRW had a positive cash flow from operations.
In the past 5 years CHRW has always been profitable.
CHRW had a positive operating cash flow in each of the past 5 years.
CHRW Yearly Net Income VS EBIT VS OCF VS FCFCHRW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

With an excellent Return On Assets value of 8.79%, CHRW belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
CHRW's Return On Equity of 27.04% is amongst the best of the industry. CHRW outperforms 84.21% of its industry peers.
CHRW's Return On Invested Capital of 18.86% is amongst the best of the industry. CHRW outperforms 89.47% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHRW is significantly above the industry average of 11.36%.
Industry RankSector Rank
ROA 8.79%
ROE 27.04%
ROIC 18.86%
ROA(3y)10.27%
ROA(5y)10.53%
ROE(3y)39.83%
ROE(5y)37.63%
ROIC(3y)22.71%
ROIC(5y)21.34%
CHRW Yearly ROA, ROE, ROICCHRW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

CHRW has a better Profit Margin (2.63%) than 68.42% of its industry peers.
In the last couple of years the Profit Margin of CHRW has declined.
CHRW has a better Operating Margin (3.96%) than 63.16% of its industry peers.
In the last couple of years the Operating Margin of CHRW has declined.
CHRW has a Gross Margin (15.60%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CHRW has declined.
Industry RankSector Rank
OM 3.96%
PM (TTM) 2.63%
GM 15.6%
OM growth 3Y-6.94%
OM growth 5Y-6.06%
PM growth 3Y-10.41%
PM growth 5Y-6.96%
GM growth 3Y4.57%
GM growth 5Y-1.58%
CHRW Yearly Profit, Operating, Gross MarginsCHRW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

5

2. Health

2.1 Basic Checks

CHRW has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CHRW has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHRW has less shares outstanding
CHRW has a better debt/assets ratio than last year.
CHRW Yearly Shares OutstandingCHRW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CHRW Yearly Total Debt VS Total AssetsCHRW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

The Debt to FCF ratio of CHRW is 3.25, which is a good value as it means it would take CHRW, 3.25 years of fcf income to pay off all of its debts.
CHRW has a better Debt to FCF ratio (3.25) than 73.68% of its industry peers.
CHRW has a Debt/Equity ratio of 0.54. This is a neutral value indicating CHRW is somewhat dependend on debt financing.
CHRW has a Debt to Equity ratio (0.54) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 3.25
Altman-Z N/A
ROIC/WACC2.22
WACC8.49%
CHRW Yearly LT Debt VS Equity VS FCFCHRW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.28 indicates that CHRW should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.28, CHRW is doing good in the industry, outperforming 63.16% of the companies in the same industry.
CHRW has a Quick Ratio of 1.28. This is a normal value and indicates that CHRW is financially healthy and should not expect problems in meeting its short term obligations.
CHRW's Quick ratio of 1.28 is fine compared to the rest of the industry. CHRW outperforms 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
CHRW Yearly Current Assets VS Current LiabilitesCHRW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.75% over the past year.
The Earnings Per Share has been growing slightly by 1.49% on average over the past years.
The Revenue has been growing slightly by 0.73% in the past year.
CHRW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.97% yearly.
EPS 1Y (TTM)39.75%
EPS 3Y-10.66%
EPS 5Y1.49%
EPS Q2Q%142%
Revenue 1Y (TTM)0.73%
Revenue growth 3Y-8.45%
Revenue growth 5Y2.97%
Sales Q2Q%-0.88%

3.2 Future

The Earnings Per Share is expected to grow by 9.04% on average over the next years. This is quite good.
Based on estimates for the next years, CHRW will show a small growth in Revenue. The Revenue will grow by 2.76% on average per year.
EPS Next Y9.92%
EPS Next 2Y14.06%
EPS Next 3Y9.7%
EPS Next 5Y9.04%
Revenue Next Year-1.04%
Revenue Next 2Y1.77%
Revenue Next 3Y2.17%
Revenue Next 5Y2.76%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CHRW Yearly Revenue VS EstimatesCHRW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
CHRW Yearly EPS VS EstimatesCHRW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

CHRW is valuated rather expensively with a Price/Earnings ratio of 22.42.
CHRW's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CHRW to the average of the S&P500 Index (29.63), we can say CHRW is valued slightly cheaper.
With a Price/Forward Earnings ratio of 20.40, CHRW is valued on the expensive side.
68.42% of the companies in the same industry are more expensive than CHRW, based on the Price/Forward Earnings ratio.
CHRW is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.42
Fwd PE 20.4
CHRW Price Earnings VS Forward Price EarningsCHRW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHRW is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHRW is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 28.09
EV/EBITDA 16.4
CHRW Per share dataCHRW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CHRW has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.26
PEG (5Y)15.08
EPS Next 2Y14.06%
EPS Next 3Y9.7%

5

5. Dividend

5.1 Amount

CHRW has a Yearly Dividend Yield of 2.51%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.82, CHRW pays a better dividend. On top of this CHRW pays more dividend than 89.47% of the companies listed in the same industry.
CHRW's Dividend Yield is comparable with the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 2.51%

5.2 History

The dividend of CHRW has a limited annual growth rate of 4.21%.
CHRW has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of CHRW decreased in the last 3 years.
Dividend Growth(5Y)4.21%
Div Incr Years2
Div Non Decr Years2
CHRW Yearly Dividends per shareCHRW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CHRW pays out 63.30% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CHRW is growing, but earnings are growing more, so the dividend growth is sustainable.
DP63.3%
EPS Next 2Y14.06%
EPS Next 3Y9.7%
CHRW Yearly Income VS Free CF VS DividendCHRW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
CHRW Dividend Payout.CHRW Dividend Payout, showing the Payout Ratio.CHRW Dividend Payout.PayoutRetained Earnings

C.H. ROBINSON WORLDWIDE INC

NASDAQ:CHRW (2/21/2025, 8:08:47 PM)

After market: 100.88 0 (0%)

100.88

+0.46 (+0.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)01-29 2025-01-29/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners96.08%
Inst Owner Change2.42%
Ins Owners0.84%
Ins Owner Change2.4%
Market Cap11.93B
Analysts72.26
Price Target118.66 (17.62%)
Short Float %4.55%
Short Ratio4.76
Dividend
Industry RankSector Rank
Dividend Yield 2.51%
Yearly Dividend2.51
Dividend Growth(5Y)4.21%
DP63.3%
Div Incr Years2
Div Non Decr Years2
Ex-Date03-07 2025-03-07 (0.62)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.09%
Min EPS beat(2)6.62%
Max EPS beat(2)9.57%
EPS beat(4)4
Avg EPS beat(4)17.26%
Min EPS beat(4)6.62%
Max EPS beat(4)35.25%
EPS beat(8)5
Avg EPS beat(8)2.98%
EPS beat(12)7
Avg EPS beat(12)3.3%
EPS beat(16)10
Avg EPS beat(16)5.81%
Revenue beat(2)1
Avg Revenue beat(2)-3.39%
Min Revenue beat(2)-7.38%
Max Revenue beat(2)0.6%
Revenue beat(4)2
Avg Revenue beat(4)-2.12%
Min Revenue beat(4)-7.38%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-3.59%
Revenue beat(12)3
Avg Revenue beat(12)-3.14%
Revenue beat(16)7
Avg Revenue beat(16)-0.27%
PT rev (1m)1.21%
PT rev (3m)11.53%
EPS NQ rev (1m)2.5%
EPS NQ rev (3m)34.09%
EPS NY rev (1m)-1.09%
EPS NY rev (3m)1.85%
Revenue NQ rev (1m)-3.51%
Revenue NQ rev (3m)-4.22%
Revenue NY rev (1m)-3.14%
Revenue NY rev (3m)-3.26%
Valuation
Industry RankSector Rank
PE 22.42
Fwd PE 20.4
P/S 0.67
P/FCF 28.09
P/OCF 23.91
P/B 6.92
P/tB N/A
EV/EBITDA 16.4
EPS(TTM)4.5
EY4.46%
EPS(NY)4.95
Fwd EY4.9%
FCF(TTM)3.59
FCFY3.56%
OCF(TTM)4.22
OCFY4.18%
SpS149.94
BVpS14.57
TBVpS-1.22
PEG (NY)2.26
PEG (5Y)15.08
Profitability
Industry RankSector Rank
ROA 8.79%
ROE 27.04%
ROCE 23.6%
ROIC 18.86%
ROICexc 19.84%
ROICexgc 58.37%
OM 3.96%
PM (TTM) 2.63%
GM 15.6%
FCFM 2.39%
ROA(3y)10.27%
ROA(5y)10.53%
ROE(3y)39.83%
ROE(5y)37.63%
ROIC(3y)22.71%
ROIC(5y)21.34%
ROICexc(3y)24.29%
ROICexc(5y)22.87%
ROICexgc(3y)65.92%
ROICexgc(5y)55.86%
ROCE(3y)29.14%
ROCE(5y)27.4%
ROICexcg growth 3Y7.04%
ROICexcg growth 5Y2.46%
ROICexc growth 3Y-8.08%
ROICexc growth 5Y-4.04%
OM growth 3Y-6.94%
OM growth 5Y-6.06%
PM growth 3Y-10.41%
PM growth 5Y-6.96%
GM growth 3Y4.57%
GM growth 5Y-1.58%
F-Score6
Asset Turnover3.35
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 3.25
Debt/EBITDA 1.15
Cap/Depr 76.46%
Cap/Sales 0.42%
Interest Coverage 250
Cash Conversion 62.44%
Profit Quality 91.15%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z N/A
F-Score6
WACC8.49%
ROIC/WACC2.22
Cap/Depr(3y)99.97%
Cap/Depr(5y)86.13%
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.41%
Profit Quality(3y)150.71%
Profit Quality(5y)108.59%
High Growth Momentum
Growth
EPS 1Y (TTM)39.75%
EPS 3Y-10.66%
EPS 5Y1.49%
EPS Q2Q%142%
EPS Next Y9.92%
EPS Next 2Y14.06%
EPS Next 3Y9.7%
EPS Next 5Y9.04%
Revenue 1Y (TTM)0.73%
Revenue growth 3Y-8.45%
Revenue growth 5Y2.97%
Sales Q2Q%-0.88%
Revenue Next Year-1.04%
Revenue Next 2Y1.77%
Revenue Next 3Y2.17%
Revenue Next 5Y2.76%
EBIT growth 1Y31.9%
EBIT growth 3Y-14.8%
EBIT growth 5Y-3.27%
EBIT Next Year18.86%
EBIT Next 3Y10.78%
EBIT Next 5Y8.56%
FCF growth 1Y-34.48%
FCF growth 3Y160.19%
FCF growth 5Y-11.11%
OCF growth 1Y-31.86%
OCF growth 3Y73.8%
OCF growth 5Y-9.8%